Uma N. M. Rao

Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma

F. Stephen Hodi, David F. McDermott, Uma N. M. Rao et al. · JAMA · 2014 · 355 citations

Medicine, Oncology, Pharmacotherapy +17

Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas†

Jianhua Luo, Bao‐Guo Ren, Sergei Keryanov et al. · Hepatology · 2006 · 340 citations · Full text

Life Sciences, Genetics, Oncology +14

Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab

Ahmad A. Tarhini, Howard Edington, Lisa H. Butterfield et al. · PLoS ONE · 2014 · 311 citations · Full text

Medicine, Immunology, Oncology +17

Neoadjuvant Treatment of Regional Stage IIIB Melanoma With High-Dose Interferon Alfa-2b Induces Objective Tumor Regression in Association With Modulation of Tumor Infiltrating Host Cellular Immune Responses

Stergios Moschos, Howard Edington, Stephanie R. Land et al. · Journal of Clinical Oncology · 2006 · 244 citations · Full text

Medicine, Immunology, Oncology +17

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609

Ahmad A. Tarhini, Sandra J. Lee, F. Stephen Hodi et al. · Journal of Clinical Oncology · 2019 · 177 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17